BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 19892177)

  • 21. Refolding and simultaneous purification by three-phase partitioning of recombinant proteins from inclusion bodies.
    Raghava S; Barua B; Singh PK; Das M; Madan L; Bhattacharyya S; Bajaj K; Gopal B; Varadarajan R; Gupta MN
    Protein Sci; 2008 Nov; 17(11):1987-97. PubMed ID: 18780821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solubilization of active green fluorescent protein from insoluble particles by guanidine and arginine.
    Tsumoto K; Umetsu M; Kumagai I; Ejima D; Arakawa T
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1383-6. PubMed ID: 14652027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adsorptive refolding of a highly disulfide-bonded inclusion body protein using anion-exchange chromatography.
    Chen Y; Leong SS
    J Chromatogr A; 2009 Jun; 1216(24):4877-86. PubMed ID: 19419725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
    Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
    Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The high pH and pH-shift refolding technology.
    Lin X; Umetsu T
    Curr Pharm Biotechnol; 2010 Apr; 11(3):293-9. PubMed ID: 20210740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli.
    Patra AK; Mukhopadhyay R; Mukhija R; Krishnan A; Garg LC; Panda AK
    Protein Expr Purif; 2000 Mar; 18(2):182-92. PubMed ID: 10686149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated refolding techniques for Schistosoma japonicum MTH1 overexpressed as inclusion bodies in Escherichia coli.
    Feng Y; Liu L; Wang J; Liu J; Hu W; Wang X; Yang Z
    Protein Expr Purif; 2012 Aug; 84(2):181-7. PubMed ID: 22641057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient production of a correctly folded mouse α-defensin, cryptdin-4, by refolding during inclusion body solubilization.
    Tomisawa S; Sato Y; Kamiya M; Kumaki Y; Kikukawa T; Kawano K; Demura M; Nakamura K; Ayabe T; Aizawa T
    Protein Expr Purif; 2015 Aug; 112():21-8. PubMed ID: 25913370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant murine growth hormone from E. coli inclusion bodies: expression, high-pressure solubilization and refolding, and characterization of activity and structure.
    Fradkin AH; Boand CS; Eisenberg SP; Rosendahl MS; Randolph TW
    Biotechnol Prog; 2010; 26(3):743-9. PubMed ID: 20196161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and extraction of insoluble (inclusion-body) proteins from Escherichia coli.
    Palmer I; Wingfield PT
    Curr Protoc Protein Sci; 2012 Nov; Chapter 6():6.3.1-6.3.20. PubMed ID: 23151747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using High Pressure and Alkaline pH for Refolding.
    Morganti L; Chura-Chambi RM
    Methods Mol Biol; 2023; 2617():177-187. PubMed ID: 36656524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An efficient in vitro refolding of recombinant bacterial laccase in Escherichia coli.
    Mollania N; Khajeh K; Ranjbar B; Rashno F; Akbari N; Fathi-Roudsari M
    Enzyme Microb Technol; 2013 May; 52(6-7):325-30. PubMed ID: 23608500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IGF1 inclusion bodies: A QbD based process approach for efficient USP as well as early DSP unit operations.
    Metzger KFJ; Padutsch W; Pekarsky A; Kopp J; Voloshin AM; Kühnel H; Maurer M
    J Biotechnol; 2020 Mar; 312():23-34. PubMed ID: 32114153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solubilization of Expressed Proteins from Inclusion Bodies.
    Kielkopf CL; Bauer W; Urbatsch IL
    Cold Spring Harb Protoc; 2021 Feb; 2021(2):. PubMed ID: 33526420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification of recombinant ovalbumin from inclusion bodies of Escherichia coli.
    Upadhyay V; Singh A; Panda AK
    Protein Expr Purif; 2016 Jan; 117():52-8. PubMed ID: 26390939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wanted: more monitoring and control during inclusion body processing.
    Humer D; Spadiut O
    World J Microbiol Biotechnol; 2018 Oct; 34(11):158. PubMed ID: 30341583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2.
    Esfandiar S; Hashemi-Najafabadi S; Shojaosadati SA; Sarrafzadeh SA; Pourpak Z
    Biotechnol Appl Biochem; 2010 Apr; 55(4):209-14. PubMed ID: 20236092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-reducing alkaline solubilization and rapid on-column refolding of recombinant prion protein.
    Walsh DJ; Noble GP; Piro JR; Supattapone S
    Prep Biochem Biotechnol; 2012; 42(1):77-86. PubMed ID: 22239709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial Inclusion Bodies: A Treasure Trove of Bioactive Proteins.
    Singhvi P; Saneja A; Srichandan S; Panda AK
    Trends Biotechnol; 2020 May; 38(5):474-486. PubMed ID: 31954528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensification of Inclusion Body Processing via Temperature-Based Refolding.
    Wong RS; Alias NNM; Ong EBB; Liew MWO
    Methods Mol Biol; 2023; 2617():189-200. PubMed ID: 36656525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.